People · Operator

Grant Van Rooyen

Named in public records as an officer, director or promoter · active 2010–2017 · Investment Vehicle, Other Technology

2
Companies
3
Filings
$207.4M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Stonepeak Claremont Holdings LPInvestment VehicleSeries D+$110.7M$1.9B2017
Cologix Holdings, Inc.Other TechnologySeries C$96.6M$2.4B2010
Operator network

Grant Van Rooyen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Neil Hobbs · 2 companies · 1 sharedNeil HobbsBill Fathers · 1 companies · 1 sharedBill FathersBrian McMullen · 1 companies · 1 sharedBrian McMullenGraham Williams · 1 companies · 1 sharedGraham WilliamsHeidi Diemar · 1 companies · 1 sharedHeidi DiemarPeter Bruce · 1 companies · 1 sharedPeter BruceTrent Vichie · 1 companies · 1 sharedTrent VichiePatrick Hendy · 6 companies · 2 sharedPatrick HendyBrian Cox · 5 companies · 2 sharedBrian CoxJohn Siegel · 9 companies · 1 sharedJohn SiegelHeidi B. Diemar · 1 companies · 1 sharedHeidi B. DiemarJohn D. Belkin · 1 companies · 1 sharedJohn D. BelkinTodd Coleman · 1 companies · 1 sharedTodd ColemanStonepeak Claremont Holdings LP · $110.7M raisedStonepeak Claremont H…Cologix Holdings, Inc. · $96.6M raisedCologix Holdings, Inc.Grant Van RooyenGR
Grant Van Rooyen Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Grant Van Rooyen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Patrick Hendy26
Brian Cox25
John Siegel19
Neil Hobbs12
Trent Vichie11
Peter Bruce11
Brian McMullen11
Heidi Diemar11
Graham Williams11
Bill Fathers11
Todd Coleman11
Heidi B. Diemar11
John D. Belkin11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.